Company Filing History:
Years Active: 2022
Title: David G Miguez: Innovator in Protein Therapeutics
Introduction
David G Miguez is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of protein therapeutics, focusing on the design of chimeric proteins that minimize toxicity while retaining therapeutic efficacy. His innovative approach has the potential to revolutionize how protein drugs are developed and administered.
Latest Patents
David G Miguez holds a patent for "Chimeric activators: quantitatively designed protein therapeutics and uses thereof." This invention provides methods for harnessing the potential of naturally occurring proteins that have serious but finite toxicity. The invention relates to a quantitative systems-biological and structural approach to design a class of chimeric proteins that avoid the toxicity of protein drugs while retaining their desired activities. In particular, these chimeric proteins contain a variant form of a natural protein fused to a targeting moiety, allowing for targeted delivery of therapeutic signals to specific cells without causing generalized toxic effects. He has 1 patent to his name.
Career Highlights
David G Miguez is affiliated with Harvard College, where he continues to advance his research in protein therapeutics. His work is characterized by a strong emphasis on innovative design and application of protein-based therapies. His contributions have been recognized within the scientific community, and he is regarded as a leading figure in his field.
Collaborations
David has collaborated with notable scientists, including Pamela Ann Silver and Pablo Gabriel Cironi Lopez. These collaborations have further enriched his research and have led to advancements in the understanding and application of protein therapeutics.
Conclusion
David G Miguez is a trailblazer in the field of protein therapeutics, with a focus on designing chimeric proteins that enhance therapeutic efficacy while reducing toxicity. His innovative work at Harvard College and his patent contributions mark him as a significant figure in the scientific community.